Advertisement

Effects of (+)-tubocurarine on [3H]acetylcholine release from the rat phrenic nerve at different stimulation frequencies and train lengths

  • I. Wessler
  • J. Rasbach
  • B. Scheuer
  • U. Hillen
  • H. Kilbinger
Article

Summary

The effect of (+)-tubocurarine (TC) on the release of [3H]acetylcholine from the rat phrenic nerve-hemidiaphragm preincubated with [3H]choline was investigated at different stimulation frequencies and train lengths.

At 0.5 Hz (100 pulses) TC failed to modulate the evoked acetylcholine release. A slight (30%) inhibition was observed at 1 Hz (100 pulses). Release of acetylcholine evoked at 5, 25 and 50 Hz (100 pulses) or 100 Hz (200 pulses) was markedly reduced by TC. The degree of inhibition (60%) was similar between 5 Hz and 100 Hz. A concentration of 1 μmol/l TC was a maximal effective concentration at 5 Hz whilst at all higher stimulation frequencies a 10-fold higher concentration was necessary for the maximal effect. When 300 pulses were continuously applied at 5 Hz or 50 Hz TC caused only a slight inhibition (20%). Additionally, the phrenic nerve was stimulated intermittently. Trains of 15 pulses were repeated 10 times with an interval of 3 s between each train. Under this latter stimulation condition TC failed to reduce acetylcholine release.

It is concluded that nicotinic autofacilitation of acetylcholine release from the motor nerve operates at frequencies and stimulation conditions similar to the pattern of nerve activity under in vivo conditions. At least more than 15 pulses are required before the nicotinic autofacilitation becomes apparent. It appears unlikely that the TC induced fading of end-organ responses can only be attributed to a blockade of the presynaptic nicotine receptors.

Key words

Motor nerve [3H]Acetylcholine release Nicotinic autofacilitation Fading 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bennett MR, Fisher C (1977) The effect of calcium ions on the binominal parameters that control acetylcholine release during transmission of the nerve impulse at amphibian neuromuscular synapses. J Physiol 271:673–698Google Scholar
  2. Betz WJ (1970) Depression of transmitter release at the neuromuscular junction of the frog. J Physiol 206:629–644Google Scholar
  3. Blackman JG (1963) Stimulus frequency and neuromuscular block. Br J Pharmacol 20:5–16Google Scholar
  4. Bowman WC (1980) Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg 59:935–943Google Scholar
  5. Bowman WC (1985) The neuromuscular junction: recent developments. Eur J Anaesth 2:59–93Google Scholar
  6. Dreyer F (1982) Acetylcholine receptor. Br J Anaesth 54:115–130Google Scholar
  7. Fischbach GD, Robbins N (1969) Changes in contractile properties of disused soleus muscles. J Physiol 201:305–320Google Scholar
  8. Gibb AJ, Marshall IG (1984) Pre- and post-junctional effects of tubocurarine and other nicotinic antagonists during repetitive stimulation in the rat. J Physiol 351:275–297Google Scholar
  9. Glavinović MI (1979) Presynaptic action of curare. J Physiol 290:499–506Google Scholar
  10. Grimby L, Hannerz J (1977) Firing rate and recruitment order of toe extensor motor units in different modes of voluntary contraction. J Physiol 264:865–879Google Scholar
  11. Grimby L, Hannerz J, Hedman B (1979) Contraction time and voluntary discharge properties of individual short toe extensor motor units in man. J Physiol 289:191–201Google Scholar
  12. Hubbard JI, Wilson DF (1973) Neuromuscular transmission in a mammalian preparation in the absence of blocking drugs and the effect of D-tubocurarine. J Physiol 228:307–325Google Scholar
  13. Kilbinger H, Wessler I (1983) The variation of acetylcholine release from the myenteric neurones with stimulation frequency and train length. Role of presynaptic muscarine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 324:130–133Google Scholar
  14. Lee C, Katz RL (1977) Fade of neurally evoked compound electromyogram during neuromuscular block by d-tubocurarine. Anesth Analg 56:271–275Google Scholar
  15. MacIntosh FC, Collier B (1976) Neurochemistry of cholinergic terminal. In: Zaimis E (ed) Neuromuscular junction, vol 42. Handb Exp Pharmacol. Springer, Berlin Heidelberg New York, pp 99–228Google Scholar
  16. Magleby KL, Pallotta BS, Terrar DA (1981) The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse and frog. J Physiol 312:97–113Google Scholar
  17. Norsted T, Jonzon A, Sedin G (1985) Continuous positive airway pressure increases vagal and phrenic nerve activity in cats. Acta Anaesth Scand 29:418–423Google Scholar
  18. Silver A (1974) The biology of cholinesterases. In: Neuberger A, Tatum EL (eds) Frontiers of biology, vol 36. North-Holland, Amsterdam OxfordGoogle Scholar
  19. St. John WM, Bartlett D (1985) Comparison of phrenic motoneuron activity in eupnea and apneusis. Respir Physiol 60:347–355Google Scholar
  20. Storella RJ, Bierkamper GG (1986) Frequency-dependence of neuromuscular blockade in the presence of d-tubocurarine. Eur J Pharmacol 124:143–148Google Scholar
  21. Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1–9Google Scholar
  22. Wessler I, Kilbinger H (1986) Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn-Schmiedeberg's Arch Pharmacol 334:357–364Google Scholar
  23. Wessler I, Halank M, Rasbach J, Kilbinger H (1986) Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve. Naunyn-Schmiedeberg's Arch Pharmacol 334:365–372Google Scholar
  24. Wessler I, Scheuer B, Kilbinger H (1987) [3H]Acetylcholine release from the phrenic nerve is increased or decreased by activation or desensitization of nicotine receptor. Eur J Pharmacol (in press)Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • I. Wessler
    • 1
  • J. Rasbach
    • 1
  • B. Scheuer
    • 1
  • U. Hillen
    • 1
  • H. Kilbinger
    • 1
  1. 1.Pharmakologisches Institut der Universität MainzMainzFederal Republic of Germany

Personalised recommendations